Trial intelligence / Profile preview

PTAS for Symptomatic Intracranial Atherosclerosis

NCT02689037Phase 3Unknown

Sponsor
476th Hospital of the People's Liberation Army
Start
Apr 2016
Primary completion
Dec 2018
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by 476th Hospital of the People's Liberation Army. Primary endpoint: Proportion of patients with events of stroke or death at 30 days. Status: unknown.

Beyond the preview

Go deeper on NCT02689037.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02689037.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call